Panelists discuss how patient-reported outcomes including symptom burden, treatment-related adverse effects, preserved functionality, and impact on quality of life should be prioritized alongside ...

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

Kat M. Aguilar, MPH, discussed findings on social determinants of health and cancer mortality and their practical ...

An international study led by a researcher at the University of Sharjah has uncovered groundbreaking findings that may ...

Subgroup analyses suggest that select patients with distal or medium artery strokes may benefit from endovascular treatment, ...

By elevating patient perspectives from an afterthought to a core part of the process, payers can create a system that aligns ...

AnnJi Pharmaceutical has reported encouraging outcomes from its randomised, placebo-controlled Phase I/IIa trial of AJ201.

Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...

They provide a structured way to measure the quality of life for patients. Patient-reported outcomes (PROs) specifically capture the patient’s direct perspective on disease burden, treatment ...

The increased rate of venous thromboembolism among patients with chronic kidney disease (CKD) warrants increased clinical attention.

A radionuclide treatment for non-melanoma skin cancer is well tolerated and effective for patients with shallow skin lesions, according to researchers.